Key result
Specific cancer treatments are associated with increased stroke risk in lung cancer patients.
Why the study?
Do specific cancer treatments increase the risk of stroke in patients with lung cancer?
Meta-Analysis
Do specific cancer treatments increase the risk of stroke in patients with lung cancer?
Specific lung cancer treatments, notably left upper lobectomy and tyrosine kinase inhibitors, are associated with an elevated risk of stroke, highlighting the need for targeted risk mitigation strategies in this population.
Answers are grounded in this paper and cite their sources.
May warrant stroke risk mitigation during lung cancer therapies; leaves open optimal strategies pending high-quality prospective studies.
Background Lung cancer survivors can be at risk of stroke because of either malignancy or treatments. This systematic review with meta-analysis identified the risk of stroke associated with cancer treatments among patients with lung cancer. Methods The Ovid MEDLINE, Embase, and Web of Science were systematically searched from inception to March 5, 2025. We included studies reporting the association between any cancer treatment and the incidence of stroke among patients with lung cancer. The titles and abstracts screening, full-text review, and quality assessment were performed by two independent researchers, and discrepancies were resolved through consensus. Data were pooled in a meta-analysis using the RStudio software to assess the association of left upper lobectomy (LUL) with stroke. Results The search resulted in 1616 distinct records, and 20 observational studies were included in the final analysis. The risk for postoperative stroke (PS) was found to be most significant within 0–30 days after pneumonectomy/lobectomy. The site of lobectomy was associated with the risk of PS in lung cancer survivors, with LUL having a higher risk relative to other lobectomies (RR random = 3.64, 95 % CI = 1.01 to 13.15). Tyrosine kinase inhibitors were associated with an elevated risk of stroke. The risk for stroke was higher for surgery+radiotherapy, surgery+chemotherapy, and surgery+chemotherapy+radiotherapy recipients compared to surgery-only recipients. Conclusions This study identified several potential cancer treatment-related risk factors for stroke in patients with lung cancer. Our findings call for high quality prospective studies to assess treatment-related risk factors for stroke and develop risk mitigation strategies for lung cancer survivors.
No takes yet. Share an insight, caveat, or question.
Ezeja et al. (2026) conducted a meta-analysis in Lung cancer. Left upper lobectomy (LUL) vs. Other lobectomies was evaluated on Postoperative stroke (RR 3.64, 95% CI 1.01 to 13.15). Left upper lobectomy was associated with a higher risk of postoperative stroke relative to other lobectomies in lung cancer survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: